Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial.
Shiozawa M, Sunakawa Y, Watanabe T, Ota H, Yasui H, Yabuno T, Tei M, Kochi M, Manaka D, Ohori H, Yamaguchi T, Sagawa T, Kotaka M, Kubota Y, Sekikawa T, Nakamura M, Takeuchi M, Ichikawa W, Fujii M, Tsuji A.
Shiozawa M, et al. Among authors: yamaguchi t.
Nat Commun. 2024 Nov 25;15(1):10217. doi: 10.1038/s41467-024-54460-2.
Nat Commun. 2024.
PMID: 39587053
Free PMC article.
Clinical Trial.